Skip to content
★ Sign in to follow
SM

Susan M. Kanaya

Chief Financial Officer
Total declarations
163
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (63 ops.)
€33.0M

Latest filing published 24 Oct 2022 for ChemoCentryx, Inc..

Filing timeline

BuySale
Susan M. Kanaya

Insider track record

Disclosed buys
0
Disclosed sells
63
Signal history

Susan M. Kanaya: trading record in brief

Susan M. Kanaya (finance chief) discloses dealings in ChemoCentryx, Inc. to SEC (Form 4). The record holds 163 filings, for trades running from 1 October 2012 to 20 October 2022.

The open-market record consists of 63 sales worth €33.0M, with no purchase. The rest of the record consists of 9 share grants and 89 option exercises. 2022 to date brings no purchases and 2 sales.

The latest filing, published on 24 October 2022, reports a transaction in ChemoCentryx, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Susan M. Kanaya

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations163 total

25 of 163 declarations